1[1]Ellenrieder V,Hendler SF,Ruhland C,et al.TGF-beta-induced invasiveness of pancreatic cells ismediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system[J].Int J Cancer,2001,93:204-211.
2[2]Rowland-Goldsmith MA, Maruyama H, Matsuda K,et al.Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer metastasis[J].Mol Cancer Ther,2002,1:161-167.
3[3]Dunn SE,Torres JV,Oh JS,et al.Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase[J].Cancer Rs,2001,61:1367-1374.
4[4]Zhang H,Morisaki T,Matsunaga H,et al.Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs[J].Clin Exp Metastasis,2000,18:343-352.
5[5]Farina AR,Tacconelli A,Cappabbianca L,et al.Inhibition of Human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen[J].Eur J Biochem,2002,269:4476-4483.
6[6]Emenaker NJ,Calaf GM,Cox D, et al.Short-chain fatty acids inhibit invasive human colon cancer by modulating uPA,TIMP-1,TIMP-2,mutant p53,Bcl-2,Bax,p21 and PCNA protein expression in an in vitro cell culture model[J].J Nutr,2001,131:S3041-S3046.
7[7]Andreasen PA,Kjoller L,Christensen L,et al .The Urokinase-type plasminogen activator system in cancer metastasis[J].Int J Cancer,1997,72:1-22.
8[8]M'Liss A,Hudson L,Michelle MR,et al.Urokinase and the urokinase receptor:Association with in vitro Invasiveness of Human Bladder Cancer Cell lines[J].J National Can Institute,1997,89:709-717.
9[9]Hudson MA,McReynold LM.Urokinase (v-PA) and the v-PA receptor.Madulation of in vitro invasiveness of human bladder cancer cell lines[J].Adv Exp Med Biol,1999,462:399-412.
10[10]Seddighzadeh M,Steineck G,Larsson P,et al.Expression of UPA and UPAR is associated with the clinical course of urinary bladder neoplasms[J].Int J Cancer,2002,99:721-726.